Intraprostatic Botulinum Toxin injection in patients with benign prostatic enlargement
2009

Botulinum Toxin Injection for Benign Prostatic Enlargement

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): Ilie CP, Chancellor MB, Chuang YC, Mischianu D

Primary Institution: Carol Davila University of Medicine and Pharmacy

Hypothesis

Can botulinum toxin type A (BTX–A) alleviate symptoms of benign prostatic hyperplasia (BPH)?

Conclusion

BTX–A injections are effective in relieving symptoms associated with BPH.

Supporting Evidence

  • BTX–A injections led to a significant reduction in prostate volume.
  • Patients reported symptomatic relief after BTX–A treatment.
  • The study showed a decrease in post-void residual volume after treatment.

Takeaway

Doctors can use a special medicine called botulinum toxin to help men with prostate problems feel better.

Methodology

The study involved injecting BTX–A into the prostate of men with BPH and measuring symptom relief and prostate volume changes.

Limitations

The study suggests the need for larger randomized clinical trials to confirm findings.

Participant Demographics

Men over 50 years of age with benign prostatic hyperplasia.

Statistical Information

P-Value

p=0.00001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication